What is Lite Run?
Lite Run operates at the intersection of medical robotics and physical therapy, providing a patented system engineered to assist individuals in regaining the ability to stand and walk following debilitating injuries or neurological events such as strokes. By prioritizing safety and rapid recovery, the company has positioned itself as a key player in the assistive technology landscape. Its platform is designed to bridge the gap between intensive clinical care and patient independence, offering a scalable solution that addresses the growing global need for effective mobility restoration. The company's focus on cost-effective, high-impact outcomes distinguishes it from traditional rehabilitation modalities, making it a significant entity in the evolving field of medical device innovation.
How much funding has Lite Run raised?
Lite Run has raised a total of $3M across 1 funding round:
Debt
$3M
Debt (2026): $3M, investors not publicly disclosed
Key Investors in Lite Run
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Lite Run?
With this major enterprise-level funding, Lite Run is well-positioned to accelerate its operational footprint and expand its clinical reach. The strategic deployment of this capital will likely focus on scaling manufacturing capabilities, enhancing research and development for next-generation mobility systems, and broadening market penetration across rehabilitation centers. As the company transitions into this growth phase, the focus will remain on optimizing patient outcomes through technological refinement and strategic partnerships. By leveraging this financial momentum, Lite Run aims to solidify its market position as a leader in mobility-focused healthcare, ultimately driving long-term value for both clinical providers and patients seeking to regain their mobility and overall wellbeing.
See full Lite Run company page
